Leflunomide Products | Cleanchem - Ledipasvir is a direct-acting antiviral agent used in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection, particularly genotype 1. It inhibits the HCV NS5A protein, which is essential for viral replication. The ledipasvir-sofosbuvir combination offers high cure rates and is generally well tolerated. Common side effects include fatigue and headache.

Leflunomide

Cat. No: CL-LFMD-01

CAS No: 75706-12-6

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

Leflunomide EP Impurity A

Cat. No: CL-LFMD-02

CAS No: 455-14-1

Mol. F: C7H6F3N

Mol. Wt: 161.1

Inv. Status: In Stock

4-(Trifluoromethyl)aniline

Cat. No: CL-LFMD-03

CAS No: 163451-81-8

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

Leflunomide EP Impurity C

Cat. No: CL-LFMD-04

CAS No: 61643-23-0

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

Leflunomide EP Impurity D

Cat. No: CL-LFMD-05

CAS No: 42831-50-5

Mol. F: C5H5NO3

Mol. Wt: 127.1

Inv. Status: Custom Synthesis

Leflunomide EP Impurity E

Cat. No: CL-LFMD-06

CAS No: 208401-20-1

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

Leflunomide EP Impurity F

Cat. No: CL-LFMD-07

CAS No: 1403564-06-6

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

Leflunomide EP Impurity G

Cat. No: CL-LFMD-08

CAS No: 724429-16-7

Mol. F: C12H12N2O2

Mol. Wt: 216.2

Inv. Status: Custom Synthesis

Leflunomide EP Impurity H

Cat. No: CL-LFMD-09

CAS No: 24522-30-3

Mol. F: C10H7F3N2O

Mol. Wt: 228.2

Inv. Status: Custom Synthesis

Leflunomide Metabolite Ethyl Analog

Cat. No: CL-LFMD-10

CAS No: 2734292-21-6

Mol. F: C13H11F3N2O2

Mol. Wt: 284.2

Inv. Status: Custom Synthesis

Leflunomide Related Compound (Methyl 5-Methyl-1,2-Oxazole-3-Carboxylate)

Cat. No: CL-LFMD-11

CAS No: 19788-35-3

Mol. F: C6H7NO3

Mol. Wt: 141.1

Inv. Status: Custom Synthesis

Leflunomide Impurity 1

Cat. No: CL-LFMD-12

CAS No: 419534-37-5

Mol. F: C10H7F3N2O

Mol. Wt: 228.2

Inv. Status: Custom Synthesis

Leflunomide Impurity 2

Cat. No: CL-LFMD-13

CAS No: 17153-20-7

Mol. F: C5H5NO3

Mol. Wt: 127.1

Inv. Status: Custom Synthesis

Leflunomide Impurity 3

Cat. No: CL-LFMD-14

CAS No: 2772495-33-5

Mol. F: C19H14F3N3O3

Mol. Wt: 389.3

Inv. Status: Custom Synthesis

3-Trifluoro Isomer

Cat. No: CL-LFMD-15

CAS No: 63927-52-6

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

3-Methylisoxazole-4-Carboxylic Acid Ethyl Ester

Cat. No: CL-LFMD-16

CAS No: 20328-15-8

Mol. F: C7H9NO3

Mol. Wt: 155.2

Inv. Status: Custom Synthesis

Teriflunomide-E Isomer

Cat. No: CL-LFMD-18

CAS No: 108605-62-5

Mol. F: C12H9F3N2O2

Mol. Wt: 270.2

Inv. Status: Custom Synthesis

5-Methylisoxazole-3-Carboxylic-d4 Acid

Cat. No: CL-LFMD-19

CAS No: 1267623-84-6

Mol. F: C5HD4NO3

Mol. Wt: 131.1

Inv. Status: Custom Synthesis

Leflunomide D4

Cat. No: CL-LFMD-20

CAS No: 1189987-23-2

Mol. F: C12H5D4F3N2O2

Mol. Wt: 274.3

Inv. Status: Custom Synthesis